[Kinin-modifying therapy of patients with myocardial infarction].
According to clinical characteristics and serum levels of alpha 1-proteinase inhibitor in the acute period (1-3 days), four groups of patients with myocardial infarction were identified. The most severe myocardial infarction was observed in patients from Groups 1 and 4. It was found that the serum alpha 1-proteinase inhibitor ratios in acute myocardial infarction were closely related to its clinical course. In the authors' opinion, determination of alpha 1-proteinase inhibitor titers by the rapid method will allow the goal-oriented therapeutical measures, including inhibitor therapy to be used.
Miagkov
I I
II
Trotsiuk
V R
VR
Iasnitskaia
M Ia
MIa
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D011379:Prognosis; D013997:Time Factors; D000515:alpha 1-Antitrypsin / Q000032:analysis / Q000627:therapeutic use*
D000515:alpha 1-Antitrypsin
Kininomoduliruiushchaia terapiia bol'nykh infarktom miokarda.